These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34767766)

  • 61. Comment on "The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review".
    Medepalli VM; Liles JE; Davis LS
    J Am Acad Dermatol; 2020 Sep; 83(3):e205-e206. PubMed ID: 32407739
    [No Abstract]   [Full Text] [Related]  

  • 62. Low affordability may limit the effect of cervical cancer vaccination in central and eastern European countries.
    Zubor P; Danko J; Kajo K; Szunyogh N
    J Clin Oncol; 2007 Dec; 25(34):5534-7. PubMed ID: 18048836
    [No Abstract]   [Full Text] [Related]  

  • 63. Human papillomavirus vaccination in female pediatric cancer survivors.
    Hoffman L; Okcu MF; Dreyer ZE; Suzawa H; Bryant R; Middleman AB
    J Pediatr Adolesc Gynecol; 2012 Oct; 25(5):305-7. PubMed ID: 22831900
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reply to: "Comment on 'The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review'".
    Pham CT; Juhasz M; Sung CT; Mesinkovska NA
    J Am Acad Dermatol; 2020 Sep; 83(3):e207. PubMed ID: 32437722
    [No Abstract]   [Full Text] [Related]  

  • 65. Exploring Knowledge and Attitudes About Human Papillomavirus Vaccination Among School Nurses in an Urban School District.
    Selvan P; Kearney M; Cognetti D; Massey P; Leader A
    J Sch Health; 2021 Feb; 91(2):125-132. PubMed ID: 33314171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monitoring of human papillomavirus vaccination.
    Dillner J; Arbyn M; Unger E; Dillner L
    Clin Exp Immunol; 2011 Jan; 163(1):17-25. PubMed ID: 21062269
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
    Temkin SM; Seibel NL
    Cancer; 2015 Oct; 121(19):3395-402. PubMed ID: 26110510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.
    Klosky JL; Russell KM; Canavera KE; Gammel HL; Hodges JR; Foster RH; Parra GR; Simmons JL; Green DM; Hudson MM
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1101-10. PubMed ID: 23983087
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The estimated impact of natural immunity on the effectiveness of human papillomavirus vaccination.
    Matthijsse SM; Hontelez JAC; Naber SK; van Rosmalen J; Rozemeijer K; Penning C; Bakker R; van Ballegooijen M; de Kok IMCM; de Vlas SJ
    Vaccine; 2015 Oct; 33(41):5357-5364. PubMed ID: 26348405
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human papillomavirus vaccine: widening the scope for cancer prevention.
    No JH; Kim MK; Jeon YT; Kim YB; Song YS
    Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mathematical analysis of a human papillomavirus transmission model with vaccination and screening.
    Zhang K; Wang XW; Liu H; Ji YP; Pan QW; Wei YM; Ma M
    Math Biosci Eng; 2020 Aug; 17(5):5449-5476. PubMed ID: 33120561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties.
    Staras SAS; Huo T; Rothbard SM; Hall JM; Cho HD; Guo Y; Richardson E; Salloum RG; Thompson LA; Silver NL; Shenkman EA
    Am J Prev Med; 2021 Dec; 61(6):812-820. PubMed ID: 34384654
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Towards global prevention of human papillomavirus-induced cancer.
    Roden RB; Gravitt P; Wu TC
    Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
    [No Abstract]   [Full Text] [Related]  

  • 74. Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination.
    Brisson M; Drolet M; Malagón T
    J Natl Cancer Inst; 2013 Feb; 105(3):158-61. PubMed ID: 23297040
    [No Abstract]   [Full Text] [Related]  

  • 75. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Role of Nursing in Preventing HPV-Related Cancers.
    Baldwin CM
    Clin J Oncol Nurs; 2020 Oct; 24(5):471. PubMed ID: 32945790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Diseases caused by human papillomavirus -- the possibilities and the public health advantages of prevention].
    Acs N; Bata Z; Danko D; Hernádi Z; Kálmán M; Kornya L; Kovács J; Mézáros G; Molnár MP; Mór Z; Novák Z; Sobel G; Szentirmay Z; Takács L; Tisza T
    Orv Hetil; 2012 Dec; 153 Suppl():3-38. PubMed ID: 23687666
    [No Abstract]   [Full Text] [Related]  

  • 78. New quadrivalent HPV vaccine developments.
    Tovar JM; Bazaldua OV
    Postgrad Med; 2008 Nov; 120(4):14-6. PubMed ID: 19020361
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gardasil administration to hr-HPV-positive women and their partners.
    Gizzo S; Noventa M; Nardelli GB
    Trends Pharmacol Sci; 2013 Sep; 34(9):479-80. PubMed ID: 23896431
    [No Abstract]   [Full Text] [Related]  

  • 80. HPV vaccines and cervical cancer.
    Bosch FX
    Ann Oncol; 2008 Jul; 19 Suppl 5():v48-51. PubMed ID: 18611900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.